Traws Pharma develops investigational antiviral medicines for respiratory viral diseases such as influenza and COVID-19. It last closed at $0.23 on Nov 17, down 10.27% on the day.
TRAW · as of the Nov 17 close · updated after every close
Downtrend, nearing oversold
The stock is 25% below its 20 day and 78% below its 50 day average. It is 347% below its 200 day average, so the longer trend is down. Momentum is fading (RSI 33), near oversold. The nearest support is the 52 week low at $0.22, and the nearest resistance the Pivot at $0.25.
Short trendBearish
Long trendBearish
MomentumFading
StretchNear oversold
VolatilityHigh, 16.4%/day
Key levels
$3.2352 week high+1304.3%
$1.04200 day average+352.2%
$0.51100 day average+121.7%
$0.4250 day average+82.6%
$0.30Swing high (Nov 12)+30.4%
$0.2920 day average+26.1%
$0.26Pivot R1+13.0%
$0.25Pivot+8.7%
$0.23Last close
$0.2252 week low−4.3%
$0.22Pivot S1−4.3%
$0.22Swing low (Nov 5)−4.3%
Indicators
RSI (14)
33.27
Weak, oversold below 30
Neutral
MACD
-0.05
Below its signal line
Bearish
Stochastic
19.4
Near the bottom of its range
Oversold
ADX (14)
28.0
Trending down
Williams %R
-90.3
Oversold below −80, overbought above −20
Oversold
CCI (20)
-71.8
Oversold below −100, overbought above 100
Neutral
Rate of change
−22.8%
Change over 10 sessions
Bearish
ATR (14)
$0.04
Typical daily range, 16.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumFading
StretchNear oversold
VolatilityHigh, 82.5%/day
Key levels
$3.2352 week high+1304.3%
$1.04200 day average+352.2%
$0.51100 day average+121.7%
$0.4250 day average+82.6%
$0.30Swing high (Nov 12)+30.4%
$0.2920 day average+26.1%
$0.26Pivot R1+13.0%
$0.25Pivot+8.7%
$0.23Last close
$0.2252 week low−4.3%
$0.22Pivot S1−4.3%
$0.22Swing low (Nov 5)−4.3%
Indicators
RSI (14)
31.32
Weak, oversold below 30
Neutral
MACD
-0.26
Above its signal line
Bullish
Stochastic
4.0
Near the bottom of its range
Oversold
ADX (14)
9.8
No clear trend
Williams %R
-97.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-141.8
Oversold below −100, overbought above 100
Oversold
Rate of change
−58.7%
Change over 10 sessions
Bearish
ATR (14)
$0.19
Typical daily range, 82.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for TRAW
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how TRAW did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow TRAW usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How TRAW has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2013.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TRAW is in one of them and how their past TRAW trades turned out.
Traws Pharma is a clinical stage biopharmaceutical company based in Newtown, Pennsylvania. It is developing investigational antiviral medicines for respiratory viral diseases, including influenza, bird flu and COVID-19. Its main candidate, tivoxavir marboxil, is being studied as a single dose oral treatment and as a monthly oral option to prevent influenza. The company also has cancer programs in clinical development. Its candidates are aimed at patients, and none is yet approved for sale.